北京民康百草医药科技有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
10
NMPA:10
Drug Approvals
Iron Proteinsuccinylate Oral Solution
- Product Name
- 蛋白琥珀酸铁口服溶液
- Approval Number
- 国药准字H20253235
- Approval Date
- Jan 24, 2025
NMPA
Fudosteine Oral Solution
- Product Name
- 福多司坦口服溶液
- Approval Number
- 国药准字H20244662
- Approval Date
- Aug 20, 2024
NMPA
Ambroxol Hydrochloride Drops
- Product Name
- 盐酸氨溴索滴剂
- Approval Number
- 国药准字H20243803
- Approval Date
- Jul 23, 2024
NMPA
Magnesium Sulfate Injection
- Product Name
- 硫酸镁注射液
- Approval Number
- 国药准字H20243142
- Approval Date
- Feb 6, 2024
NMPA
Sodium Valproate Oral Solution
- Product Name
- 丙戊酸钠口服溶液
- Approval Number
- 国药准字H20234591
- Approval Date
- Dec 5, 2023
NMPA
Clinical Trials
No trials found
News
No news found